12:30 PM EST - HYTN Innovations Inc : Announces that its wholly owned subsidiary, HYTN Cannabis Inc., has received a license amendment from Health Canada allowing for the cultivation of cannabis. This License Amendment further strengthens HYTN's regulatory approvals which include a Standard Processing License, a Research License and an Amendment for Sale of Cannabis to provincially and territorially authorized retailers. HYTN Innovations Inc
shares C.HYTN are trading unchanged at $0.14.
